Search
Search Constraints
You searched for: Author/Creator Fang, ZijianLimit your search
- Fang, Zijian [remove] 6
- 519.5 1
- 543.0284 1
- 572.57 1
- 610.5 1
- 615.1 1
- 616 1
- ADRB3 β3-adrenergic receptor -- AKT protein kinase B -- AMSC adipose tissue-derived mesenchymal stem cell -- ApoM apolipoprotein M -- AP1 activator protein 1 -- aSMase acid sphingomyelinase -- αSMA α-smooth muscle actin -- ATGL adipose triglyceride lipase -- ATM adipose tissue macrophages -- BMI body mass index -- BMP bone morphogenetic protein -- CCL5 chemokine ligand 5 -- C/EBPs CCAAT/enhancer-binding proteins -- CEM caveolin-enriched micro-domains -- CerS ceramide synthase -- CL CL-316243 (β3-adrenergic agonist) -- DAG diacylglycerol -- Degs1 dihydroceramide desaturase -- DIO diet-induced obesity -- DMS dimethylsphingosine -- DHS dihydrosphingosine -- EGF epidermal growth factor -- ER endoplasmic reticulum -- ERK1/2 extracellular signal-regulated kinase 1 and 2 -- FABP4 fatty acid-binding protein 4 -- FOXO forkhead box protein O -- FTY720 fingolimod (2-Amino-2-[2-(4-octyl-phenyl)-ethyl]-propane-1, 3-diol) -- GLUT4 glucose transporter 4 -- GSK3β glycogen synthase kinase 3 beta -- GWAS genome-wide association study -- HDAC1/2 histone deacetylase 1 and 2 -- HDL high density lipoprotein -- HFD high fat diet -- HSL hormone-sensitive lipase -- IFNγ interferon gamma -- IL-1β interleukin-1β -- IKK-β inhibitor of nuclear factor kappa-B kinase subunit beta -- IR insulin receptor -- IRS insulin receptor substrate -- JAK Janus kinases -- c-JNK c-Jun N-terminal kinase -- JTE-013 S1P2 antagonist -- KC keratinocyte-derived chemokine -- LDL low density lipoprotein -- LPP lipid phosphate phosphatase -- LPS lipopolysaccharides -- MAGL monoglyceride lipase -- MAPK mitogen-activated protein kinase -- MCP-1 monocyte chemoattractant protein 1 -- mTOR mammalian target of rapamycin -- NEFA Non esterified fatty acid -- NF-κB nuclear factor kappa-light-chain-enhancer of activated B cells -- NLRP3 NACHT LRR and PYD domains-containing protein 3 -- nSMase neutral sphingomyelinase -- PCNA proliferating cell nuclear antigen -- PDE3B phosphodiesterase 3B -- PDK phosphoinositide-dependent kinases -- PHB2 prohibitin 2 -- PMA phorbol 12-myristate 13-acetate -- PI3K phosphoinositide 3-kinase -- PIP3 phosphatidylinositol (3, 4, 5)-trisphosphate -- PKA protein kinase A -- PKC protein kinase C -- PKD protein kinase D -- PLC phospholipase C -- PPARγ peroxisome proliferator-activated receptor gamma -- PP2A protein phosphatase-2A -- PTEN phosphatase and tensin homologue -- PTP1B protein-tyrosine phosphatase 1B -- S1P sphingosine 1-phosphate -- S1P1-5 S1P receptor 1-5 -- S6K ribosomal protein S6 kinase -- SPHK I or SKI-II (2-(p-Hydroxyanilino)-4-(p-chlorophenyl) thiazole) -- Smpd1 acid sphingomyelinase gene -- SphK sphingosine kinase -- SOCS3 Suppressor of cytokine signaling 3 -- SPT serine palmitoyl transferase -- SREBF1 sterol regulatory element-binding transcription factor 1 -- STAT3 signal transducer and activator of transcription 3 -- T2D type 2 diabetes -- TGFβ transforming growth factor beta -- TLR Toll-like receptors -- TNFα tumor necrosis factor alpha -- TRAF2 TNF receptor-associated factor 2 -- UCP-1 uncoupling protein-1 -- VEGF vascular endothelial growth factor -- VLDL very low density lipoprotein -- VPC23019 S1P1/3 antagonist -- ZLC Zucker lean normoglycemic control -- 5c 2, 2-dimethyl-4S-(1-oxo-2-hexadecyn-1-yl)-1, 1-dimethylethylester-3-oxazolidine-carboxylic acid. 1
- Bayesian time series -- cyber threats -- MCMC -- SIS -- SIR 1
- Chemistry, Analytic -- Periodicals 1
- Chemotherapy -- Periodicals 1